 Enoxacin
"Enoxacin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A broad-spectrum 6-fluoronaphthyridinone antibacterial agent (FLUOROQUINOLONES) structurally related to NALIDIXIC ACID.
| Descriptor ID |
D015365
|
| MeSH Number(s) |
D03.438.810.835.322.280
|
| Concept/Terms |
Penetrex- Penetrex
- Rhône-Poulenc Rorer Brand of Enoxacin Sesquihydrate
- Rhône Poulenc Rorer Brand of Enoxacin Sesquihydrate
Enoxin- Enoxin
- Faulding Brand of Enoxacin
Enoxor- Enoxor
- Pierre Fabre Brand of Enoxacin Sesquihydrate
|
Below are MeSH descriptors whose meaning is more general than "Enoxacin".
Below are MeSH descriptors whose meaning is more specific than "Enoxacin".
This graph shows the total number of publications written about "Enoxacin" by people in Harvard Catalyst Profiles by year, and whether "Enoxacin" was a major or minor topic of these publication.
Below are the most recent publications written about "Enoxacin" by people in Profiles.
-
Melo S, Villanueva A, Moutinho C, Davalos V, Spizzo R, Ivan C, Rossi S, Setien F, Casanovas O, Simo-Riudalbas L, Carmona J, Carrere J, Vidal A, Aytes A, Puertas S, Ropero S, Kalluri R, Croce CM, Calin GA, Esteller M. Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci U S A. 2011 Mar 15; 108(11):4394-9.
-
Breger J, Fuchs BB, Aperis G, Moy TI, Ausubel FM, Mylonakis E. Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog. 2007 Feb; 3(2):e18.
-
Schaeffer AJ. The expanding role of fluoroquinolones. Am J Med. 2002 Jul 8; 113 Suppl 1A:45S-54S.
-
Marchbanks CR, Mikolich DJ, Mayer KH, Zinner SH, Dudley MN. Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infections. Antimicrob Agents Chemother. 1990 Oct; 34(10):1966-72.
-
Zinner SH. Clinical overview of enoxacin. Clin Pharmacokinet. 1989; 16 Suppl 1:59-64.
-
Blaser J, Stone BB, Groner MC, Zinner SH. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrob Agents Chemother. 1987 Jul; 31(7):1054-60.
-
Blaser J, Dudley MN, Gilbert D, Zinner SH. Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin. Antimicrob Agents Chemother. 1986 May; 29(5):927-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|